Metropolis Healthcare Limited - Asset Resilience Ratio

Latest as of September 2025: 4.49%

Metropolis Healthcare Limited (METROPOLIS) has an Asset Resilience Ratio of 4.49% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs894.99 Million
≈ $9.68 Million USD Cash + Short-term Investments

Total Assets

Rs19.93 Billion
≈ $215.49 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Metropolis Healthcare Limited's Asset Resilience Ratio has changed over time. Check Metropolis Healthcare Limited strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Metropolis Healthcare Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Metropolis Healthcare Limited.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs600.86 Million 3.02%
Short-term Investments Rs294.13 Million 1.48%
Total Liquid Assets Rs894.99 Million 4.49%

Asset Resilience Insights

  • Limited Liquidity: Metropolis Healthcare Limited maintains only 4.49% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Metropolis Healthcare Limited Industry Peers by Asset Resilience Ratio

Compare Metropolis Healthcare Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
LONZA GROUP UNSP.ADR 1/10
F:LO3A
Diagnostics & Research 3.04%
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB
Diagnostics & Research 13.43%
BGI Genomics Co Ltd
SHE:300676
Diagnostics & Research 3.62%
Fleury S.A.
SA:FLRY3
Diagnostics & Research 16.06%
Centro de Imagem Diagnósticos S.A
SA:AALR3
Diagnostics & Research 4.77%
Inoviq Ltd
AU:IIQ
Diagnostics & Research 56.29%
RHYTHM Biosciences Ltd
AU:RHY
Diagnostics & Research 2.74%
Immunovia publ AB
ST:IMMNOV
Diagnostics & Research 83.99%

Annual Asset Resilience Ratio for Metropolis Healthcare Limited (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Metropolis Healthcare Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 4.38% Rs817.54 Million
≈ $8.84 Million
Rs18.67 Billion
≈ $201.95 Million
+0.58pp
2024-03-31 3.80% Rs590.32 Million
≈ $6.38 Million
Rs15.55 Billion
≈ $168.17 Million
-0.96pp
2023-03-31 4.75% Rs713.61 Million
≈ $7.72 Million
Rs15.02 Billion
≈ $162.39 Million
-3.99pp
2022-03-31 8.74% Rs1.34 Billion
≈ $14.46 Million
Rs15.30 Billion
≈ $165.50 Million
-23.09pp
2021-03-31 31.83% Rs3.20 Billion
≈ $34.57 Million
Rs10.04 Billion
≈ $108.62 Million
+17.93pp
2020-03-31 13.90% Rs1.05 Billion
≈ $11.31 Million
Rs7.52 Billion
≈ $81.35 Million
+5.23pp
2019-03-31 8.67% Rs479.07 Million
≈ $5.18 Million
Rs5.53 Billion
≈ $59.77 Million
-11.82pp
2018-03-31 20.49% Rs1.09 Billion
≈ $11.75 Million
Rs5.30 Billion
≈ $57.35 Million
-8.20pp
2017-03-31 28.69% Rs1.48 Billion
≈ $15.98 Million
Rs5.15 Billion
≈ $55.71 Million
+3.19pp
2016-03-31 25.50% Rs1.01 Billion
≈ $10.92 Million
Rs3.96 Billion
≈ $42.82 Million
-10.44pp
2015-03-31 35.94% Rs1.67 Billion
≈ $18.02 Million
Rs4.64 Billion
≈ $50.13 Million
+2.68pp
2014-03-31 33.26% Rs1.31 Billion
≈ $14.12 Million
Rs3.93 Billion
≈ $42.45 Million
--
pp = percentage points

About Metropolis Healthcare Limited

NSE:METROPOLIS India Diagnostics & Research
Market Cap
$321.61 Million
Rs29.74 Billion INR
Market Cap Rank
#14275 Global
#731 in India
Share Price
Rs573.75
Change (1 day)
+5.22%
52-Week Range
Rs421.75 - Rs2236.70
All Time High
Rs3431.71
About

Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinic… Read more